News

In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of the GLP-1 field. | BrightGene ...
Scholar Rock's Apitegromab excels in Phase 2 trials, aiding muscle preservation with Tirzepatide. Click here to read why I ...
The NHS has just announced a major change made to Mounjaro access as 1,600,000 people are now expected to receive the weight ...
GPs in England will have the new ability to prescribe weight loss injections on the NHS as part of a mass rollout aimed at ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
The American College of Cardiology has issued new guidelines recommending weight management medications as first-line ...
For patients with obesity, clinicians should move beyond a "try and fail" approach to lifestyle interventions and prioritize ...
The American College of Cardiology has issued a Concise Clinical Guidance (CCG) document to aid clinicians in the use of ...
Shares of Scholar Rock Holdings jumped Wednesday after the biopharmaceutical firm reported positive results from a ...